papaverine and sulfinpyrazone
papaverine has been researched along with sulfinpyrazone in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Novo, S; Strano, A | 1 |
Ciosek, CP; Newcombe, DS; Thanassi, NM | 1 |
Perlick, E | 1 |
Anzai, T; Ogawa, J; Suzuki, T; Takano, S | 1 |
Takács, M; Vámos, J; Volford, O | 1 |
Reviews
1 review(s) available for papaverine and sulfinpyrazone
Article | Year |
---|---|
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Dipyridamole; Epoprostenol; Humans; Hyperlipidemias; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Sulfinpyrazone; Xanthines | 1979 |
Other Studies
7 other study(ies) available for papaverine and sulfinpyrazone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Cartilage cyclic nucleotide phosphodiesterase: inhibition by anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Bucladesine; Cartilage; Cartilage, Articular; Chickens; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Epiphyses; Gold; Indomethacin; Kinetics; Mefenamic Acid; Oxyphenbutazone; Papaverine; Phenylbutazone; Phosphodiesterase Inhibitors; Quinolines; Structure-Activity Relationship; Sulfinpyrazone; Theophylline; Tritium | 1974 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nucleosides; Papaverine; Plasminogen; Serine; Sulfinpyrazone; Thromboplastin; Thrombosis | 1968 |
Effects of antianginal drugs on platelet aggregation of rabbits.
Topics: Angina Pectoris; Animals; Nitroglycerin; Papaverine; Platelet Aggregation; Rabbits; Sulfinpyrazone; Vasodilator Agents | 1980 |
[Ion exchange interactions on silica gel in thin-layer chromatography. IV. Plate investigations by UV spectroscopy].
Topics: Benzoates; Benzoic Acid; Chromatography, Ion Exchange; Chromatography, Thin Layer; Papaverine; Pharmaceutical Preparations; Phenobarbital; Salicylates; Salicylic Acid; Silanes; Silica Gel; Silicon Dioxide; Spectrophotometry, Ultraviolet; Sulfacetamide; Sulfinpyrazone | 1996 |